Redrow PLC
OTC:RDWWF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Redrow PLC
OTC:RDWWF
|
UK |
|
O
|
Orogen Royalties Inc
F:5EV
|
CA |
|
T
|
Tryptamine Therapeutics Ltd
ASX:ENP
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RDWWF's stock price target?
Not Available
RDWWF does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Redrow PLC?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is -3%.
What is the Operating Income forecast for Redrow PLC?
Projected CAGR
-13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 30%. The projected CAGR for the next 3 years is -13%.